New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 29, 2013
11:28 EDTRDYDr. Reddy's announces the launch of Zenatane
Dr. Reddy’s Laboratories announced that it has launched Zenatane, Isotretinoin Capsules USP, in 20 mg and 40 mg, a therapeutically equivalent generic version of Accutane, Isotretinoin Capsules USP, in the US market on March 28, 2013 following the approval by the United States Food & Drug Administration, USFDA, of Dr. Reddy’s ANDA for Zenatane™ 10 mg, 20 mg and 40 mg. The total market had U.S. sales of approximately $309 Million for the most recent twelve months ending January 2013 according to IMS Health*. Dr. Reddy’s Zenatane™ Capsules 10 mg, 20 mg, & 40 mg will be available in boxes of 30, 3 prescription packs of 10 capsules, as unit dose blisters.
News For RDY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for RDY

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use